Combined Antioxidant, Anti-inflammaging and Mesenchymal Stem Cell Treatment: A Possible Therapeutic Direction in Elderly Patients with Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Combined Antioxidant, Anti-inflammaging and Mesenchymal Stem Cell Treatment: A Possible Therapeutic Direction in Elderly Patients with Chronic Obstructive Pulmonary Disease

Published:2020 Issue:1 Volume:11 Page:129
ISSN:2152-5250
Container-title:Aging and disease
language:en
Short-container-title:Aging and disease

Author:

Shijin Xia,Changxi Zhou,Bill Kalionis,Xiaoping Shuang,Haiyan Ge,Wen Gao

Publisher

Aging and Disease

Subject

Cell Biology,Clinical Neurology,Geriatrics and Gerontology,Pathology and Forensic Medicine

Link

http://www.aginganddisease.org/fileup/2152-5250/PDF/ad-0-0-0-1905111454-1.pdf

Reference91 articles.

1. Mortality GBD, Causes of Death C (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388: 1459-1544

2. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. (2015). Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health, 5: 020415

3. Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, et al. (2018). Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 391: 1706-1717

4. Srivastava K, Thakur D, Sharma S, Punekar YS (2015). Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics, 33: 467-488

5. Sullivan SD, Ramsey SD, Lee TA (2000). The economic burden of COPD. Chest, 117: 5S-9S

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for postoperative pulmonary complications in elderly patients undergoing video-assisted thoracoscopic surgery lobectomy under general anesthesia: a retrospective study;BMC Surgery;2024-05-14

2. Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic;American Journal of Stem Cells;2024

3. The role of intensive care nurses in cellular treatments during the COVID‐19 pandemic;Nursing in Critical Care;2023-10-31

4. A PILLAR OF CARDIOVASCULAR DISEASES: INFLAMMAGING;Turkish Journal of Geriatrics;2023

5. Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation;Frontiers in Nutrition;2022-11-01